CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells

BACKGROUND: Oral squamous cell carcinoma (OSCC) is the most prevalent malignant tumor in head and neck region. Platinum drug resistance limits the clinical application of chemotherapy regardless of medical development. The aim of our study is to identify cisplatin-resistant genes which can be used a...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Xue, Zhu, Li, Song, Rongbo, Shang, Chao, Guo, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982036/
https://www.ncbi.nlm.nih.gov/pubmed/36827716
http://dx.doi.org/10.1016/j.tranon.2023.101644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982036/
https://www.ncbi.nlm.nih.gov/pubmed/36827716
http://dx.doi.org/10.1016/j.tranon.2023.101644

Ejemplares similares